Applied DNA Sciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $797 | $929 | $891 | $779 |
Gross Profit | 111 | 109 | 231 | 78 |
EBITDA | -3,212 | -3,431 | -6,129 | -4,360 |
EBIT | -3,346 | -3,617 | -6,428 | -4,690 |
Net Income | 1,879 | -4,470 | -1,182 | -3,592 |
Net Change In Cash | 797 | 929 | 891 | 779 |
Free Cash Flow | -3,516 | -3,224 | -3,757 | -2,562 |
Cash | 10,442 | 3,149 | 3,359 | 7,151 |
Basic Shares | 4,014 | 871 | 683 | 678 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $13,367 | $18,168 | $9,027 | $1,931 |
Gross Profit | 5,533 | 5,053 | 4,928 | 1,210 |
EBITDA | -10,445 | -21,377 | -9,691 | -12,627 |
EBIT | -11,807 | -22,668 | -10,535 | -12,913 |
Net Income | -9,947 | -8,377 | -16,029 | -12,764 |
Net Change In Cash | 13,367 | 18,168 | 9,027 | 1,931 |
Cost of Revenue | 7,227 | |||
Free Cash Flow | -6,296 | -9,466 | -15,936 | -12,206 |
Cash | 7,151 | 15,215 | 6,554 | 7,786 |
Basic Shares | 653 | 448 | 345 | 195 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.47 |
2024-03-31 | -$5.31 |
2023-12-31 | -$0.09 |
2023-09-30 | -$0.26 |
